3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
4
Neoplasm Metastasis
3
Keratosis, Actinic
3
Warts
2
Uterine Cervical Dysplasia
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Mesothelioma
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
CIPN - Chemotherapy-Induced Peripheral Neuropathy
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Anus Neoplasms
1
Adenoma, Islet Cell
1
Interventions
Prednisone
112
Docetaxel
87
Leuprolide
79
enzalutamide
72
Abiraterone Acetate
67
bicalutamide
53
Goserelin
50
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
42
Radiotherapy
39
abiraterone
28
Magnetic Resonance Spectroscopy
27
Gonadotropin-Releasing Hormone
24
gallium 68 PSMA-11
23
apalutamide
22
Androgen Antagonists
22
luprolide acetate gel depot
21
sipuleucel-T
20
Radiosurgery
20
Triptorelin Pamoate
18
cabazitaxel
17
cabozantinib
16
Radiotherapy, Intensity-Modulated
16
Flutamide
16
pembrolizumab
15
radium Ra 223 dichloride
14
Prednisolone
14
Nivolumab
14
Dutasteride
14
Dexamethasone
14
Radiation
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Prostatic Neoplasms
×
Cryotherapy
×
Clear all
NCT04049747
2025-03-24
IP4-CHRONOS
Imperial College London
Phase NA
Completed
100 enrolled
23 charts